Financial Publications
Marinomed’s financial publications (reports, presentations etc.) are listed below in chronological order and are available to download in PDF format.
Conference Call Invitation - Results Q1 2022
Investor Presentation - Full Year Results 2021
Annual Report 2021
Sustainability Report 2021 (excerpt from Annual Report 2021)
Jahresfinanzbericht 2021 (ESEF)
Financial Report 2021
Conference Call Invitation - Full Year Results 2021
Investor Presentation Q3 2021
Update Q3 2021
Conference Call Invitation - Results Q3 2021
Bericht des Vorstands der Marinomed Biotech AG FN 276819 m, ISIN ATMARINOMED6 gemäß § 174 Abs 4 iVm § 153 Abs 4, § 171 Abs 1 AktG (German Only)
Investor Presentation H1 2021
Half-Year Financial Report 2021
Conference Call Invitation - Half-Year Results 2021
Update Q1 2021
Investor Presentation Q1 2021
Conference Call Invitation - Results Q1 2021
Jahresfinanzbericht 2020 (ESEF)
Investor Presentation - Results FY 2020
Annual Report 2020
Financial Report 2020
Conference Call Invitation - Full year results 2020
Update Q3 2020
Investor Presentation Q3
Conference Call Invitation - Results Q3 2020
Investor Presentation H1 2020
Half-Year Financial Report 2020
Conference Call Invitation - Results H1 2020
Investor Presentation SARS-CoV-2
Update Q1 2020
Investor Presentation Q1 2020
Conference Call Invitation - Results Q1 2020
Investor Presentation - Results FY 2019
Financial Report 2019
Annual Report 2019
Investor Presentation Q3 2019
Update Q3 2019
Investor Presentation H1 2019
Half-Year Financial Report 2019
Half-Year Financial Report 2019 incl. UGB
Update Q1 2019
Investors Update 2018
Veröffentlichung gemäß § 5 Abs. 2 Rechnungslegungs-Kontrollgesetz (RL-KG) vom 04.09.2020 (German only)
Financial Report 2018
Annual Report 2018
Annual Report 2017
Audit report (German language only)